MLA 0.00% 8.5¢ medical australia limited

mpts360 medivet device

  1. 96 Posts.
    The FY2013 MLA interim report mentions a new product called the Multi-Purpose Training System (MPTS360) has been commercialised by the company. There is more to this than initially meets the eye and we're bound to hear more of as time goes on.

    This product has been used on a horse called Territory, which suffered bleeding on the lung and the owners were told it would never race again. Territory was then sold to Medivet who then treated it with the MPTS360 and their Autologous Conditioned Serum (ACS) product. The horse made a full recovery and came back to win a race last Saturday (23/11/13) at Randwick.

    Here are some links to this product and story -

    http://www.prweb.com/releases/2013/11/prweb11379653.htm
    http://www.thoroughbrednews.com.au/sydney/default.aspx?id=70173
    http://www.mpts360.com/
    https://www.facebook.com/MedivetMpts360EquineNebuliser

    In reading through the MPTS360 presentation material it's obvious a lot of hard work and thought has gone into the product. Of particular note is the design of a new nebuliser that is an improvement over competitor offerings.

    Yesterday MLA and Medivet took a big step forward to becoming a single entity at the AGM. It is a great omen that a few days out Territory won and is a great story to tell going forward.
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.